| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/11/2008 | US20080221161 treatment or prevention of metabolic, cardiovascular, and inflammatory diseases; 1-(7-methoxy-2-(thiophen-3-yl)quinolin-3-yl)-N-(4-(trifluoromethyl)benzyl)methanamine |
| 09/11/2008 | US20080221129 New compounds |
| 09/11/2008 | US20080221127 Ppar active compounds |
| 09/11/2008 | US20080221113 Substituted hexahydropyrazino [1,2-a] pyrimidine-4,7-dione derivatives, process for their preparation and their use as medicaments |
| 09/11/2008 | US20080221108 Anthranilic Acid Derivatives As Hm74A Receptor Agonists |
| 09/11/2008 | US20080221107 6-(4-chlorophenyl)-3-{4-[(3R)-3-hydroxypyrrolidin-1-yl]-3-methoxyphenyl}thieno[3,2-d][1,2,3]triazin-4(3H)-one; Melanin concentrating hormone receptor antagonist; obesity, psychiatric disorders, cognitive disorders, memory disorders, schizophrenia, epilepsy, and neurological disorders |
| 09/11/2008 | US20080221105 1-[1-(methylsulfonyl)piperidin-4-yl]-3-(adamant-1-yl)urea, 1-[1-(acetyl)piperidin-4-yl]-3-(adamant-1-yl)urea; incipient diabetes, glucose intolerance, obesity, hypertension, high blood pressure, elevated serum cholesterol, reduced high-density lipoproteins and elevated triglyceride levels |
| 09/11/2008 | US20080221100 Soluble epoxide hydrolase inhibitors |
| 09/11/2008 | US20080221082 of the alpha V beta 3 integrin receptor; , thromboembolic events, cardiovascular disorders, lung diseases, disorders of the CNS, the kidney, the gastrointestinal tract or inflammation |
| 09/11/2008 | US20080221075 To treat obesity or diabetes; reduction of serum cholesterol and the treatment of atherosclerosis |
| 09/11/2008 | US20080221069 Novel Therapeutic Agents for the Treatment of Cancer, Metabolic Diseases and Skin Disorders |
| 09/11/2008 | US20080221023 Administering protein hydrolysates; dipeptidyl peptidase IV diseases; obesity, type II diabetes mellitus, autoimmune diseases |
| 09/11/2008 | US20080221018 Crystalline solid and amorphous forms of (-)- halofenate and methods related thereto |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220101 Compositions of extracts of aloe for oral administration |
| 09/11/2008 | US20080220096 Cynara scolymus extracts and compositions containing them |
| 09/11/2008 | US20080220092 Overcoming active agent tolerance, which may be experienced from continuous administration, improve patient compliance, and in some cases reducing the amount of drug needed per dose due to advantages of biosynchronization |
| 09/11/2008 | US20080219973 Using antigalectin-3 immunoglobulin as therapeutic in prevention and treatment of glomerulonephritis, diabetic nephropathy and/or tissue fibrosis |
| 09/11/2008 | US20080219958 Treating neuroblastoma in mammals via exposure to tumor antigen pulsed antigen-presenting cells; tissue targeted therapy; immunotherapy |
| 09/11/2008 | US20080219956 Hla homozygous cells and methods of use thereof |
| 09/11/2008 | US20080219953 Cosmid dna constructs and methods of making and using same |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1967199A1 Cynara scolymus extracts and compositions containing them |
| 09/10/2008 | EP1967198A1 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity |
| 09/10/2008 | EP1967195A1 Antacid |
| 09/10/2008 | EP1966221A1 Pyrimido- [4, 5-]-oxazines for use as dgat inhibitors |
| 09/10/2008 | EP1966215A1 Condensed heterocyclic compounds useful as dpp-iv inhibitors |
| 09/10/2008 | EP1966204A1 Novel heterocyclic oxime derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
| 09/10/2008 | EP1966199A1 Azaindole-2-carboxamide derivatives |
| 09/10/2008 | EP1966183A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 09/10/2008 | EP1966152A2 Glucokinase activators |
| 09/10/2008 | EP1966133A2 Crystal form of atorvastatin hemi-calcium and processes for preparation thereof |
| 09/10/2008 | EP1965862A2 Combination of an h3 antagonist/inverse agonist and an appetite suppressant |
| 09/10/2008 | EP1965830A1 Use of alkaline phosphatase to maintain healthy tissue mass in mammals |
| 09/10/2008 | EP1965810A1 Preparation for treatment of mineral deficiency |
| 09/10/2008 | EP1965783A1 Treatment of type 2 diabetes with a combination of dpiv inhibitor and metformin or thiazolidinedione |
| 09/10/2008 | EP1965642A2 Pyrazolyl carboxamides |
| 09/10/2008 | EP1729598B1 Composition; use of a composition and a method for preventing fat absorption |
| 09/10/2008 | EP1658071B1 Cyanoguanidine-based azole compounds useful as malonyl-coa decarboxylase inhibitors |
| 09/10/2008 | EP1633883B1 Method for assaying lkb1 phosphorylation activity |
| 09/10/2008 | EP1626715B1 Use of sulphonamide derivatives for the manufacture of a medicament for the prophylaxis and/or treatment of disorders of food ingestion |
| 09/10/2008 | EP1605954B1 A food-supplement composition suitable for promoting iron absorption |
| 09/10/2008 | EP1478732B1 A selenium yeast product, a method of preparing a selenium yeast product and the use of the product for preparing food, a dietary supplement or a drug |
| 09/10/2008 | EP1323710B1 Nitrogenous five-membered ring compounds |
| 09/10/2008 | EP1312374B1 Primrose seed extracts as sugar absorption inhibitors and process for producing the same |
| 09/10/2008 | EP1303284B1 Compositions and methods for the treatment of skin damage |
| 09/10/2008 | EP1301474B1 Tyrosine derivatives as phosphatase inhibitors |
| 09/10/2008 | EP1285908B1 Substituted phenylpropionic acid derivatives |
| 09/10/2008 | EP1159006B1 Water-soluble compositions of bioactive lipophilic compounds |
| 09/10/2008 | EP1141017B1 Characterization of the soc/crac calcium channel protein family |
| 09/10/2008 | EP1131356B1 Monoclonal anti alpha-D (ITGAD) antibody for use in the treatment of CNS injuries caused by trauma |
| 09/10/2008 | CN201111422Y Medical mineral substance adhesive film |
| 09/10/2008 | CN101263140A Heterobicyclic compounds as glucokinase activators |
| 09/10/2008 | CN101263134A Midazole-4-carboxamide derivatives for use as CB modulators |
| 09/10/2008 | CN101263120A 4,5-dihydro-1h-pyrazole derivatives, their preparation and use as medicaments |
| 09/10/2008 | CN101263119A Novel 1,2-dihydroquinoline derivative having glucocorticoid receptor binding activity |
| 09/10/2008 | CN101263114A Crystalline and amorphous sodium atorvastatin |
| 09/10/2008 | CN101263112A Histamine H3 receptor agents, preparation and therapeutic uses |
| 09/10/2008 | CN101263111A Processes for the preparation of (3R,4S)-4-((4-benzyloxy)phenyl)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-2-beta-azetidinone, an intermediate for the synthesis of ezetimibe |
| 09/10/2008 | CN101260103A Compound with portion PPARgamma excitant activity and application thereof |
| 09/10/2008 | CN101260086A Protein-tyrosine-phosphatase 1B inhibitor and its preparation method and use |
| 09/10/2008 | CN101260072A Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 09/10/2008 | CN101259278A Optimum matching multiple water-soluble vitamin medicinal composition containing high-efficiency bacteriostat and preparation thereof |
| 09/10/2008 | CN101259276A Method of selecting substance characterized by assaying PPARdelta activating effect and drug |
| 09/10/2008 | CN101259266A Preadipocyte heterologous vaccine and preparation method and application thereof |
| 09/10/2008 | CN101259263A Medicaments assembly for treating stomach-heat moisture resistance type obesity and preparation thereof |
| 09/10/2008 | CN101259261A Diabetes treating traditional Chinese medicine |
| 09/10/2008 | CN101259220A Blood sugar reducing diabetes treating traditional Chinese medicinal preparations |
| 09/10/2008 | CN101259205A Medicaments assembly for treating adiposis and preparation thereof |
| 09/10/2008 | CN101259192A Method for processing camellia chrysantha pollen |
| 09/10/2008 | CN101259191A Fat-reducing health products and producing method thereof |
| 09/10/2008 | CN101259142A Bone peptide injection preparation |
| 09/10/2008 | CN101259126A Composition for treating hyperlipidemia and preparation thereof |
| 09/10/2008 | CN101259122A Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 09/10/2008 | CN101259121A Use of hydroxyoleic acid and similar compounds in the production of medicaments |
| 09/10/2008 | CN101259118A Application of 2',4'-dihydroxy-6'-methoxy-3',5'-dimethyl chalcone as PPAR gamma agonist |
| 09/10/2008 | CN101259115A Orally-administered insulin soft capsule for treating diabetes and preparation thereof |
| 09/10/2008 | CN101259102A Micrometre level docosahexaenoic acid emulsion and preparation thereof |
| 09/10/2008 | CN101259101A Micrometre level arachidonic acid/docosahexaenoic acid emulsion and preparation thereof |
| 09/10/2008 | CN101258935A Health-care spirulina food |
| 09/10/2008 | CN101258924A Postpartum recuperating body shaping soup |
| 09/10/2008 | CN101258895A Negative ion-releasing selenium-rich odor-free multifunctional feed additive |
| 09/10/2008 | CN101258875A Yoghourt useful for lowering blood fat and preparation |
| 09/10/2008 | CN100417665C Method for preparing pollen pini polyose, pollen pipe polyose and its use in medicine |
| 09/10/2008 | CN100417662C Peptide for promoting insulin release of frog and its use in production of drugs |
| 09/10/2008 | CN100417650C Vibralactone, preparation method and medicinal application thereof |
| 09/10/2008 | CN100417419C Composition and method to alter lean body mass and bone properties in a subject |
| 09/10/2008 | CN100417394C Application of plant extract for preparing medicine to cure bone absorption increment diseases and composition thereof |
| 09/10/2008 | CN100417333C Forage additive for increasing egg yield and preventing hens from peaking each other |
| 09/09/2008 | US7423185 Amino alcohol derivatives, pharmaceutical compositions containing the same, and use thereof |
| 09/09/2008 | US7423177 Carboxamide derivatives as therapeutic agents |
| 09/09/2008 | US7423162 Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives |
| 09/09/2008 | US7423067 Diphenyl cyclopentyl amides as cannabinoid-1 receptor inverse agonists |
| 09/09/2008 | US7423066 Dietetics; use in treatment of obesity, for reducing body weight, modulating body lipid metabolism, and reducing food intake |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423052 Piperidine compounds for use as orexin receptor antagoinst |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |